Short review highlights the interplay between the immune system and RAAS in hypertension, suggesting new therapeutic targets.
The renin-angiotensin-aldosterone system (RAAS) and the immune system interact in hypertension through various mechanisms, including inflammation, immune cell infiltration, oxidative stress, and aldosterone-induced hypertension. Further research is needed to fully understand the complex interplay between the RAAS and the immune system in hypertension and to identify potential therapeutic targets. Additionally, T lymphocytes, monocytes, macrophages, dendritic cells, neutrophils, and B lymphocytes are some of the immune cells that have been implicated in hypertension. These immune cells can promote vascular inflammation and remodeling, produce reactive oxygen species and cytokines, and activate the adaptive immune response. Further research is needed to fully understand the role of the immune system in hypertension and to identify potential therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Eskandarian et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: